Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line

This study has been terminated.
(due to the decision from sanofi to withdraw on a worldwide basis the Marketing Authorisation Applications for semuloparin in the adult indication)
Information provided by (Responsible Party):
Sanofi Identifier:
First received: March 28, 2012
Last updated: January 14, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)